Global Pen Needles Market Size study, by Type (Standard Pen Needles, Safety Pen Needles) By Length ( 4mm, 5mm, 6mm, 8mm, 10mm, 12mm) By Therapy (Insulin Therapy, Glucagon-Like Peptide-1 (GLP-1) Therapy, Growth Hormone Therapy, Other Therapies) By Mode of Purchase (Retail, Non-Retail) and Regional Forecasts 2019-2026

  • Product Code:
    RP-ID-10265622
  • Published Date:
    21 Oct 2022
  • Region:
    Global
  • Pages:
    200
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-14

Impact Analysis on the Growth of Market

Inflation and Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

..

..

The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.


With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.



Market Overview:

Translate Report

Global Pen Needles Market is valued approximately USD 1 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 10.8% over the forecast period 2019-2026. Pen needles are used in combination with infusion pens to provide or deliver injectable drugs into the body. A pen needle comprises of a hollow needle which is embedded in a plastic hub and attaches to injection pens. They are commonly used by people with chronic diseases who often require multiple daily injections for instance, in diabetes. Increase in diabetes have driven more people to take insulin that can be self-administered through insulin needle pen. Thus, growing prevalence of chronic diseases coupled with favorable reimbursement policies are key driving factor of market growth. According to the International Diabetic Federation, the number of diabetic patients are growing at a significant pace. As per the source the number of diabetic patients in 2015 were reported to be approximately 425 million globally whereas these number are estimated to grow about 578 million by 2030 and about 700 million by 2045. Further, growing prevalence for biosimilar drugs is expected to create significant growth opportunity in the market over the forecast period. Insulin pen needles are expected for single use however it is known that a significant proportion of people with diabetes do re-use needle pens this is expected to create significant challenge in the market. However, preference for alternative modes of drug delivery impedes the growth of the market over the forecast period of 2019-2026.

The regional analysis of global Pen Needles market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is the leading/significant region across the world in terms of market share owing to the growing geriatric population and growing prevalence of diabetes in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as increasing focus of market players developing novel product and improving healthcare infrastructure would create lucrative growth prospects for the Pen Needles market across Asia-Pacific region.

Major market player included in this report are:
Becton, Dickinson and Company
Novo Nordisk
Ypsomed
Owen Mumford, Ltd.
HTL-Strefa
B. Braun Melsungen AG
Terumo Corporation
Ultimed
Allison Medical, Inc.
Artsana S.P.A.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Standard Pen Needles
Safety Pen Needles
By Length:
4mm
5mm
6mm
8mm
10mm
12mm
By Therapy:
Insulin Therapy
Glucagon-Like Peptide-1 (GLP-1) Therapy
Growth Hormone Therapy
Other Therapies
By Mode of Purchase:
Retail
Non-Retail
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Pen Needles Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


Geography Analysis:


The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Becton, Dickinson and Company
Novo Nordisk
Ypsomed
Owen Mumford, Ltd.
HTL-Strefa
B. Braun Melsungen AG
Terumo Corporation
Ultimed
Allison Medical, Inc.
Artsana S.P.A.
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports

-->